BIOMAT Database Logo BIOMAT Database Logo

Long-term experience of spironolactone in essential hypertension. 1988

X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Service d'Hypertension Artérielle, Hôpital Broussais, Paris, France.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Long term spironolactone and the adrenal cortex in essential hypertension.
September 1980, Clinical endocrinology,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension.
May 1991, Journal of clinical pharmacology,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Long-term clinical experience with enalapril in essential hypertension.
October 1983, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Clinical experience with long-term nitrendipine treatment in essential hypertension.
January 1984, Journal of cardiovascular pharmacology,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
[Spironolactone in resistant essential hypertension].
December 2019, Presse medicale (Paris, France : 1983),
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Long-term experience of captopril in the treatment of primary (essential) hypertension.
January 1982, British journal of clinical pharmacology,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Spironolactone versus nifedipine in essential hypertension.
June 1990, The American journal of cardiology,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Reduced response of plasma aldosterone to acute ACTH stimulation during long-term treatment with spironolactone in essential hypertension.
January 1979, Hormone research,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
[Long-term prognosis of essential hypertension].
December 1971, Saishin igaku. Modern medicine,
X Jeunemaitre, and C Kreft-Jais, and G Chatellier, and J Julien, and P Degoulet, and P F Plouin, and J Ménard, and P Corvol
Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
November 1988, The American journal of cardiology,
Copied contents to your clipboard!